Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin vs Levofloxacin Regimens for H. pylori Infection
NCT07021729Phase 4Not yet recruiting
- Sponsor
- Rehman Medical Institute
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of levofloxacin in Helicobacter pylori infection (2 arms), sponsored by Rehman Medical Institute. Primary endpoint: Treatment of H pylori infection. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07021729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07021729.